When doctors diagnose dementia, they're often treating only part of the problem. A groundbreaking analysis from the University of California San Francisco (UCSF) found that 95% of older adults with an Alzheimer's disease diagnosis actually had multiple brain diseases working together. For those with Alzheimer's, the median number of different pathologies was three separate conditions. What Did the UCSF Brain Bank Study Reveal? Researchers at UCSF's Memory and Aging Center examined brain tissue from patients who had donated their brains to science. What they discovered challenged a fundamental assumption in dementia care: that most people have just one disease causing their cognitive decline. Instead, mixed dementia—where multiple pathologies exist in the same brain—is far more common than previously understood. "For older adults with a diagnosis of Alzheimer's disease, the median number of pathologies was three. So it's more the rule than the exception," explained Dr. David Soleimani-Meigooni, a neurologist at UCSF's Memory and Aging Center and assistant professor focused on precision diagnosis in Alzheimer's and related neurodegenerative diseases. The research shows that when pathologists examine brain tissue under a microscope, they use a specific sampling scheme. They take small slices from regions where different pathologies tend to concentrate, then stain the tissue to identify what's present. Based on the severity and distribution of each disease, they rank which conditions likely contributed most to the person's symptoms during life. The Three Main Diseases Found in Mixed Dementia The most common combination involves Alzheimer's disease paired with other conditions. In one documented case from UCSF, a patient's brain showed three distinct diseases: - Alzheimer's Disease: Characterized by amyloid plaques and tau protein tangles that damage brain cells and disrupt memory and thinking - Vascular Dementia: Caused by reduced blood flow to the brain, often from stroke or small vessel disease, leading to cognitive difficulties and sometimes physical symptoms like weakness - LATE (Limbic-predominant Age-related TDP-43 Encephalopathy): A newer diagnosis involving TDP-43 protein aggregates, which researchers now recognize as a major contributor to cognitive impairment in aging Beyond these three, other pathologies frequently appear alongside Alzheimer's disease. Lewy body pathology—the same protein abnormalities seen in Parkinson's disease—commonly co-occurs with Alzheimer's. The overlap is so frequent that experts believe these diseases may be biologically linked rather than coincidental. Why Does This Matter for Diagnosis and Treatment? The presence of multiple diseases explains why dementia symptoms vary so much from person to person, even when they receive the same diagnosis. One person with "Alzheimer's disease" might struggle primarily with memory loss, while another experiences changes in personality or behavior—differences that could reflect which additional pathologies are present. During a patient's lifetime, doctors typically cannot definitively identify which specific diseases are present. They rely on cognitive tests, brain imaging, and symptom patterns to make their best guess. Only a brain autopsy can reveal the true mix of pathologies. This diagnostic uncertainty has major implications: a treatment that works for pure Alzheimer's disease might not help someone whose cognitive decline is driven equally by vascular disease or TDP-43 pathology. "This is one of the fundamental questions of the 21st century," said Dr. Bruce Miller, director of the UCSF Edward and Pearl Fein Memory and Aging Center. "We're not going to be able to treat Alzheimer's until we really are able to understand and treat TDP-43. I don't think we're going to be able to treat Parkinson's until we can treat the Alzheimer pathology that co-occurs". How Doctors Rank Which Disease Caused Symptoms When a brain autopsy is performed, pathologists don't just identify what's present—they determine what likely caused the person's symptoms. They combine the neuropathological findings with the patient's medical history and symptom progression. For example, if someone gradually lost memory first and later developed movement problems, the pattern suggests Alzheimer's disease was the primary driver, with Lewy body pathology contributing secondarily. Pathologists use specific diagnostic criteria to assess severity. For Alzheimer's disease, they evaluate: - Amyloid Plaque Distribution: Using the Thal phase system to map where amyloid plaques appear throughout the brain - Plaque Density: Measured by the CERAD score, which quantifies how densely packed the plaques are in affected regions - Tau Tangle Distribution: Assessing where tau neurofibrillary tangles have accumulated and how extensively they've spread These factors are plugged into a diagnostic algorithm that assigns a severity level—such as "high Alzheimer's disease neuropathological change." The same rigorous approach applies to other pathologies, allowing pathologists to rank multiple diseases by their likely contribution to cognitive decline. Steps to Understanding Your Dementia Risk - Know Your Family History: If relatives had dementia, ask your doctor about early screening and monitoring, since multiple pathologies may run in families - Monitor Sleep Changes: Excessive daytime sleepiness can signal early cognitive decline and may indicate multiple brain pathologies at work, making it worth discussing with your healthcare provider - Track Cognitive Symptoms Carefully: Note when memory problems started, whether you struggle with specific tasks like problem-solving or communication, and any personality changes—this pattern helps doctors narrow down which diseases might be involved - Consider Brain Donation: If you're concerned about dementia, discuss brain donation with your doctor; autopsies provide definitive diagnoses that advance research and help families understand what happened What This Means for Future Treatment The discovery that mixed dementia is the norm rather than the exception is reshaping how researchers approach treatment development. Single-disease therapies may help only partially, since they address just one of multiple pathologies. Future treatments may need to target multiple brain diseases simultaneously to be truly effective. Brain donation programs like those at UCSF are accelerating this progress. Each autopsy contributes to a growing understanding of how different pathologies interact and which combinations are most common. This knowledge helps researchers develop better biomarkers—blood tests or imaging markers that could identify mixed dementia during life rather than only at autopsy. For families facing a dementia diagnosis today, understanding that multiple diseases are likely involved can shift expectations. It explains why symptoms don't always follow textbook patterns and why treatment responses vary. As diagnostic tools improve, the hope is that doctors will eventually identify the specific mix of pathologies in each patient while they're still alive, allowing for truly personalized treatment plans tailored to their unique brain disease profile.
